Related Experiment Videos
Differentiation between aberrant ventricular conduction and ventricular ectopy in atrial fibrillation using RR
A C Suyama1, K Sunagawa, M Sugimachi
1Research Institute of Angiocardiology, Kyushu University Medical School, Fukuoka, Japan.
Insights
Differentiating aberrant ventricular conduction from ventricular ectopy in atrial fibrillation (AF) is crucial. A novel RR interval scattergram technique noninvasively distinguishes these conditions, aiding clinical diagnosis and patient management.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Diagnostics
Background:
- Distinguishing aberrant ventricular conduction from ventricular ectopy during atrial fibrillation (AF) is vital for patient etiology, prognosis, and treatment.
- Current diagnostic methods may lack noninvasive precision for these conditions in AF.
Purpose of the Study:
- To develop and validate a noninvasive technique for differentiating aberrant ventricular conduction from ventricular ectopy in patients with AF.
Main Methods:
- Analysis of Holter ECGs from patients with paroxysmal and chronic AF.
- Generation of RR interval scattergrams plotting sequential RR intervals.
- Comparison of scattergram patterns for aberrant conduction versus ventricular ectopy against the atrioventricular conduction refractory period envelope.
Main Results:
- Aberrant ventricular conduction showed a specific curvilinear distribution along the RR interval scattergram envelope.
- Ventricular ectopies exhibited distinct patterns, including linear and chaotic distributions, unrelated to the envelope.
- Electrophysiological examination confirmed the diagnoses in 32 patients.
Conclusions:
- The RR interval scattergram is a valuable noninvasive tool for differentiating aberrant ventricular conduction from ventricular ectopy in AF.
- This technique enhances clinical diagnostic capabilities for complex arrhythmias.
Background:
Differentiation between aberrant ventricular conduction and ventricular ectopy during atrial fibrillation (AF) is of etiologic, prognostic, and therapeutic importance. We developed a noninvasive technique to diagnose aberrant ventricular conduction and ventricular ectopy in AF.
Methods And Results:
We studied the Holter ECGs of 34 patients with paroxysmal AF and 62 patients with chronic AF. In all the patients, frequent wide QRS complexes were observed, and 32 patients were shown by electrophysiological examination to have ventricular ectopies or aberrant ventricular conductions. We obtained the RR interval scattergrams by plotting sequential pairs of RR intervals. Each point has the (n)th RR interval as its x value and the (n + 1)th RR interval as its y value. The irregularity of the RR intervals in AF resulted in widely scattered points delineated by the envelope along the axes. The y value of the envelope along the x axis indicates the shortest coupling interval to the preceding RR interval. Therefore, this curve defines the functional refractory period of atrioventricular conduction. The scattergram of the RR interval pairs immediately preceding the aberrant conduction (coupling points of aberrant conduction) specifically distributed along the envelope. In contrast, the coupling points of ventricular ectopies showed different distributions that had no relation to the envelope. That is, it included three typical patterns, ie, linear distribution below the envelope, linear distribution partially overlapped in the area of normal AF conduction, and chaotic distribution in the AF area. None of the scattergrams of ventricular ectopies showed curvilinear distribution along the envelope as aberrant conduction did. The specific distribution of the aberrant conduction on the RR interval scattergram suggested that aberrant conduction in AF could result from the difference of refractory periods between the AV node and bundle branch block.
Conclusions:
We conclude that the RR interval scattergram makes it possible to differentiate between aberrant ventricular conduction and ventricular ectopy in atrial fibrillation, and thus, it is a useful noninvasive clinical tool.